Activity of afatinib in heavily pretreated patients with HER2 mutation-positive advanced NSCLC: findings from a global named patient use program,

Details

Request a copyRequest a copy
Serval ID
serval:BIB_0FB97EBE99F9
Type
Article: article from journal or magazin.
Publication sub-type
Minutes: analyse of a published work.
Collection
Publications
Institution
UNIL/CHUV
Title
Activity of afatinib in heavily pretreated patients with HER2 mutation-positive advanced NSCLC: findings from a global named patient use program,
Journal
Annals of Oncology
Author(s)
Peters S., Curioni-Fontecedro A., Nechushtan H., Shih J.-Y., Liao W.-Y., Gautschi O., Spataro V., Unk M., Yang JCH, Lorence RM, Carrière P., Cseh A., Chang J.C.
ISSN
0923-7534 (print)
1569-8041 (electronic)
Publication state
Published
Issued date
2017
Volume
28
Number
5
Pages
v484-v485
Language
english
OAI-PMH
oai:serval.unil.ch:BIB_0FB97EBE99F9
DOI
10.1093/annonc/mdx380.057
Create date
08/02/2018 18:02
Last modification date
29/11/2023 7:12
Usage data